NOVEN PHARMACEUTICALS INC 4
4 · NOVEN PHARMACEUTICALS INC · Filed Dec 13, 2006
Insider Transaction Report
Form 4
BARRETT DIANE
VP & Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock ($.0001 par value)
2006-12-11$10.45/sh+12,000$125,400→ 12,000 total - Sale
Common Stock ($.0001 par value)
2006-12-11$25.45/sh−2,500$63,625→ 9,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2006-12-11−12,000→ 24,000 totalExercise: $10.45Exp: 2010-11-04→ Common Stock ($.0001 par value) (12,000 underlying) - Sale
Common Stock ($.0001 par value)
2006-12-11$25.45/sh−2,000$50,894→ 7,500 total
Footnotes (1)
- [F1]20% exercisable after 11/5/2004; 20% exercisable after 11/5/2005; 20% exercisable after 11/5/2006; 20% exercisable after 11/5/2007; and 20% exercisable after 11/5/2008.